Our results showed that S2P04-tBuK inhibited SIRT2 2.7- and 152-fold more potently than SIRT1 and SIRT3, respectively, a feature shared by TB (Fig. 6b, Supplementary Table 2). Here, SIRT3 is linked to tuberculosis.